CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Change in Inventory of -$32000.0 for Q4 2025, down 328.57% on a QoQ basis from $14000.0 in Q3 2025, and down 313.33% year-over-year from $15000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Change in Inventory history runs 8 years deep, the most recent figure standing at -$32000.0 for Q4 2025.
- Quarterly Change in Inventory fell 313.33% year-over-year to -$32000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $117000.0 (down 58.21% YoY) and the FY2025 annual result came in at -$129000.0, down 146.07% from the prior year.
- Change in Inventory was -$32000.0 for Q4 2025 at CollPlant Biotechnologies, down from $14000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $856000.0 in Q4 2023 and bottomed at -$345000.0 in Q1 2023.
- A 5-year average of $55894.7 and a median of $15000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory plunged 1330.77% — and 2023, when it jumped 374.36%.
- CollPlant Biotechnologies' Change in Inventory stood at $181000.0 in 2021, then sank by 272.38% to -$312000.0 in 2022, then soared by 374.36% to $856000.0 in 2023, then sank by 98.25% to $15000.0 in 2024, then plunged by 313.33% to -$32000.0 in 2025.
- Business Quant data shows CLGN's Change in Inventory at -$32000.0 in Q4 2025, $14000.0 in Q3 2025, and $120000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 190,000.00 |